Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). It's a fast-growing blood cancer that starts in B cells (also called B lymphocytes) — white blood cells that normally help your immune system fight infections.
In DLBCL, cancerous B cells grow and divide uncontrollably Show Full Answer
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). It's a fast-growing blood cancer that starts in B cells (also called B lymphocytes) — white blood cells that normally help your immune system fight infections.
In DLBCL, cancerous B cells grow and divide uncontrollably, outnumbering healthy cells and building up in organs. DLBCL usually develops in the lymph nodes but can also appear in other parts of the body, including the:
- Stomach or intestines
- Liver
- Kidneys
- Bone marrow
- Skin
The average age at diagnosis is 64, though it can affect anyone. The good news? Although DLBCL is aggressive, it often responds well to treatment. The most common first-line treatment is a drug combination called R-CHOP, which targets the cancerous B cells directly.
June 17
Join
Your Privacy Choices
